With the recent passage of a decriminalization bill in Congress, could legislation on CBD supplements be next? For pet owners who have already witnessed the positive effects of CBD supplements, easing restrictions could lead to even more advancements that improve the health of our pets.
CBD producers often have to remind the public that their products don’t produce a psychoactive effect, which is what THC is responsible for in marijuana use. And while House Bill 3884, aimed at decriminalizing marijuana, made headlines last week when it passed in the U.S. House of Representatives, it does not directly impact CBD usage or the study of it. It is, however, a signal that CBD legislation already introduced could be one step closer to getting approved in the U.S. House of Representatives.
In August, House Bill 8179 was introduced, seeking to make it federally legal to use CBD in supplements. Better known as the “Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020,” its passage could pave the way for many more positive steps forward for this complex yet promising cannabinoid compound.
What Passing the Bill Will Do
While CBD products are legal in many states, they aren’t federally legal, which has some critics saying that the U.S. Food and Drug Administration, the agency in charge of overseeing veterinary drugs, is throwing “cold water on a hot market.”
If passed, the bill will make it federally legal to use CBD as a dietary ingredient in a dietary supplement. The FDA noted on its website in October that there is “significant interest in the development of therapies and other consumer products derived from cannabis and its components, including cannabidiol (CBD).” The agency has also said it is working to answer questions about the science, safety and quality of products containing cannabis and cannabis-derived compounds, particularly CBD.
The agency finally made a positive move in regard to CBD in July 2020 when it approved Epidiolex, a CBD-containing drug used for controlling seizures.
Douglas Throckmorton, M.D., deputy center director for regulatory programs in the FDA’s Center for Drug Evaluation and Research, said the FDA is committed to supporting “rigorous scientific research on the potential medical uses of cannabis-derived products and working with product developers who are interested in bringing patients safe and effective, high quality products.”
The FDA has also come down on CBD producers, issuing warning letters in late 2019 to 15 companies for “illegally selling products containing cannabidiol in ways that violate the Federal Food, Drug and Cosmetic Act.”
On Oct. 30, the FDA offered technical comments and some amendments to the bill, noting that simply because it was making recommendations, it was not endorsing the bill. The most notable amendment would require CBD producers and distributors to ensure their product is safe through new dietary ingredient notifications, also known as NDINs, and provide a limit the amount of CBD in their recommended dosages. Pet owners can get behind this, no doubt, because it would help to ensure the products being advertised as CBD are indeed safe to use.
At PetSoothe, we are keeping close tabs on what’s going on with CBD legislation in Washington D.C. and we’re committed to bringing the best supplements to the market. If you’ve got questions about CBD products for your pet, contact us today.